Cargando…

Structural stigma and its impact on healthcare for consumers with borderline personality disorder: protocol for a scoping review

BACKGROUND: Structural stigma in health systems experienced by consumers diagnosed with Borderline Personality Disorder (BPD) is a widespread phenomenon that causes major health inequities and harm for this population. Structural stigma in this context relates to institutional policies, cultural nor...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Pauline, Fairweather, Alicia Kate, Lawn, Sharon, Stallman, Helen Margaret, Cammell, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798332/
https://www.ncbi.nlm.nih.gov/pubmed/33423674
http://dx.doi.org/10.1186/s13643-021-01580-1
_version_ 1783635041322008576
author Klein, Pauline
Fairweather, Alicia Kate
Lawn, Sharon
Stallman, Helen Margaret
Cammell, Paul
author_facet Klein, Pauline
Fairweather, Alicia Kate
Lawn, Sharon
Stallman, Helen Margaret
Cammell, Paul
author_sort Klein, Pauline
collection PubMed
description BACKGROUND: Structural stigma in health systems experienced by consumers diagnosed with Borderline Personality Disorder (BPD) is a widespread phenomenon that causes major health inequities and harm for this population. Structural stigma in this context relates to institutional policies, cultural norms, and organizational practices that limit consumers’ access to health services, quality of care, and capacity to achieve optimal health and well-being. BPD is a serious mental illness with high morbidity and mortality, characterized by instability in interpersonal relationships, self-image, and emotional and behavioral deregulation, which stem from significant traumatic childhood/life events, and/or biological etiologies. The objectives of this scoping review are to explore the international literature on structural stigma in healthcare systems specific to BPD, and to provide an overview of the impact of structural stigma on health services for BPD consumers and their carers/families. METHODS: This scoping review will follow the Joanna Briggs Institute (JBI) scoping review guidelines. We will search the following electronic databases (from inception onwards): MEDLINE, CINAHL, PsycINFO, Scopus, Cochrane Library, and JBI-Evidence databases. Grey literature will be identified through the Google search engine. We will include all types of literature in English, published and unpublished, including any study design, reviews, clinical practice guidelines, policy reports, and other documents. No restrictions on publication date of sources of evidence will be applied. International literature should examine structural stigma associated with BPD in any healthcare setting such as, outpatients, inpatients, primary health care, or community-based facilities. Two reviewers will independently screen all titles, abstracts, and full-text citations. Quality appraisal of the included sources of evidence will be assessed using the Mixed Methods Appraisal Tool (MMAT) 2018 version. Data analysis will involve quantitative (e.g., frequencies) and qualitative (e.g., thematic analysis) methods. DISCUSSION: This review is anticipated to enhance both identification and understanding of those structures in health systems (i.e., institutional policies, cultural norms, and practices) that manifest and perpetuate stigma experienced by consumers with BPD and their carers/families. The findings can be used to inform future research, policy, and practice relating to stigma reduction strategies that can be adopted to improve the provision of BPD-responsive services and care for this population. SYSTEMATIC REVIEW REGISTRATION: Open Science Framework (https://osf.io/bhpg4). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13643-021-01580-1.
format Online
Article
Text
id pubmed-7798332
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77983322021-01-12 Structural stigma and its impact on healthcare for consumers with borderline personality disorder: protocol for a scoping review Klein, Pauline Fairweather, Alicia Kate Lawn, Sharon Stallman, Helen Margaret Cammell, Paul Syst Rev Protocol BACKGROUND: Structural stigma in health systems experienced by consumers diagnosed with Borderline Personality Disorder (BPD) is a widespread phenomenon that causes major health inequities and harm for this population. Structural stigma in this context relates to institutional policies, cultural norms, and organizational practices that limit consumers’ access to health services, quality of care, and capacity to achieve optimal health and well-being. BPD is a serious mental illness with high morbidity and mortality, characterized by instability in interpersonal relationships, self-image, and emotional and behavioral deregulation, which stem from significant traumatic childhood/life events, and/or biological etiologies. The objectives of this scoping review are to explore the international literature on structural stigma in healthcare systems specific to BPD, and to provide an overview of the impact of structural stigma on health services for BPD consumers and their carers/families. METHODS: This scoping review will follow the Joanna Briggs Institute (JBI) scoping review guidelines. We will search the following electronic databases (from inception onwards): MEDLINE, CINAHL, PsycINFO, Scopus, Cochrane Library, and JBI-Evidence databases. Grey literature will be identified through the Google search engine. We will include all types of literature in English, published and unpublished, including any study design, reviews, clinical practice guidelines, policy reports, and other documents. No restrictions on publication date of sources of evidence will be applied. International literature should examine structural stigma associated with BPD in any healthcare setting such as, outpatients, inpatients, primary health care, or community-based facilities. Two reviewers will independently screen all titles, abstracts, and full-text citations. Quality appraisal of the included sources of evidence will be assessed using the Mixed Methods Appraisal Tool (MMAT) 2018 version. Data analysis will involve quantitative (e.g., frequencies) and qualitative (e.g., thematic analysis) methods. DISCUSSION: This review is anticipated to enhance both identification and understanding of those structures in health systems (i.e., institutional policies, cultural norms, and practices) that manifest and perpetuate stigma experienced by consumers with BPD and their carers/families. The findings can be used to inform future research, policy, and practice relating to stigma reduction strategies that can be adopted to improve the provision of BPD-responsive services and care for this population. SYSTEMATIC REVIEW REGISTRATION: Open Science Framework (https://osf.io/bhpg4). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13643-021-01580-1. BioMed Central 2021-01-11 /pmc/articles/PMC7798332/ /pubmed/33423674 http://dx.doi.org/10.1186/s13643-021-01580-1 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Protocol
Klein, Pauline
Fairweather, Alicia Kate
Lawn, Sharon
Stallman, Helen Margaret
Cammell, Paul
Structural stigma and its impact on healthcare for consumers with borderline personality disorder: protocol for a scoping review
title Structural stigma and its impact on healthcare for consumers with borderline personality disorder: protocol for a scoping review
title_full Structural stigma and its impact on healthcare for consumers with borderline personality disorder: protocol for a scoping review
title_fullStr Structural stigma and its impact on healthcare for consumers with borderline personality disorder: protocol for a scoping review
title_full_unstemmed Structural stigma and its impact on healthcare for consumers with borderline personality disorder: protocol for a scoping review
title_short Structural stigma and its impact on healthcare for consumers with borderline personality disorder: protocol for a scoping review
title_sort structural stigma and its impact on healthcare for consumers with borderline personality disorder: protocol for a scoping review
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798332/
https://www.ncbi.nlm.nih.gov/pubmed/33423674
http://dx.doi.org/10.1186/s13643-021-01580-1
work_keys_str_mv AT kleinpauline structuralstigmaanditsimpactonhealthcareforconsumerswithborderlinepersonalitydisorderprotocolforascopingreview
AT fairweatheraliciakate structuralstigmaanditsimpactonhealthcareforconsumerswithborderlinepersonalitydisorderprotocolforascopingreview
AT lawnsharon structuralstigmaanditsimpactonhealthcareforconsumerswithborderlinepersonalitydisorderprotocolforascopingreview
AT stallmanhelenmargaret structuralstigmaanditsimpactonhealthcareforconsumerswithborderlinepersonalitydisorderprotocolforascopingreview
AT cammellpaul structuralstigmaanditsimpactonhealthcareforconsumerswithborderlinepersonalitydisorderprotocolforascopingreview